Yakira Capital Management Inc. acquired a new stake in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 8,499 shares of the company’s stock, valued at approximately $322,000.
A number of other hedge funds have also added to or reduced their stakes in BME. HBK Sorce Advisory LLC raised its stake in shares of BlackRock Health Sciences Trust by 14.8% during the fourth quarter. HBK Sorce Advisory LLC now owns 8,194 shares of the company’s stock valued at $311,000 after acquiring an additional 1,057 shares in the last quarter. Hara Capital LLC bought a new stake in BlackRock Health Sciences Trust during the 4th quarter valued at $832,000. AlphaStar Capital Management LLC purchased a new stake in shares of BlackRock Health Sciences Trust in the 4th quarter worth $878,000. Janney Montgomery Scott LLC grew its position in shares of BlackRock Health Sciences Trust by 40.5% during the 4th quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after buying an additional 9,455 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new position in shares of BlackRock Health Sciences Trust during the fourth quarter valued at $3,250,000.
BlackRock Health Sciences Trust Stock Down 4.8 %
NYSE:BME opened at $36.32 on Friday. BlackRock Health Sciences Trust has a 1-year low of $36.24 and a 1-year high of $42.64. The company has a 50-day moving average of $39.68 and a 200 day moving average of $39.84.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- What is Forex and How Does it Work?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What is the Euro STOXX 50 Index?
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Why is the Ex-Dividend Date Significant to Investors?
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.